Qube Research & Technologies Ltd purchased a new stake in shares of Omega Healthcare Investors Inc (NYSE:OHI) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 9,946 shares of the real estate investment trust’s stock, valued at approximately $308,000.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Millennium Management LLC bought a new position in Omega Healthcare Investors during the second quarter valued at approximately $2,050,000. Centaurus Financial Inc. purchased a new stake in shares of Omega Healthcare Investors during the second quarter valued at approximately $612,000. Tower Research Capital LLC TRC boosted its stake in shares of Omega Healthcare Investors by 56.2% during the second quarter. Tower Research Capital LLC TRC now owns 38,066 shares of the real estate investment trust’s stock valued at $1,180,000 after purchasing an additional 13,700 shares during the period. Paloma Partners Management Co purchased a new stake in shares of Omega Healthcare Investors during the second quarter valued at approximately $515,000. Finally, Macquarie Group Ltd. boosted its stake in shares of Omega Healthcare Investors by 210.0% during the second quarter. Macquarie Group Ltd. now owns 295,023 shares of the real estate investment trust’s stock valued at $9,146,000 after purchasing an additional 199,848 shares during the period. Institutional investors and hedge funds own 72.26% of the company’s stock.
A number of research firms have recently weighed in on OHI. Zacks Investment Research raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Thursday, August 16th. Wells Fargo & Co lowered Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a research note on Monday, June 25th. They noted that the move was a valuation call. ValuEngine raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Monday, August 13th. Cantor Fitzgerald reissued a “buy” rating and set a $34.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, August 6th. Finally, Stifel Nicolaus increased their price objective on Omega Healthcare Investors from $27.00 to $30.00 and gave the company a “hold” rating in a research note on Tuesday, August 7th. Nine analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Omega Healthcare Investors has an average rating of “Hold” and a consensus price target of $31.37.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Friday, August 3rd. The real estate investment trust reported $0.75 earnings per share for the quarter, beating analysts’ consensus estimates of $0.73 by $0.02. Omega Healthcare Investors had a return on equity of 2.49% and a net margin of 10.61%. The firm had revenue of $192.85 million during the quarter, compared to analyst estimates of $200.30 million. During the same quarter in the prior year, the firm posted $0.87 earnings per share. The business’s quarterly revenue was down .6% compared to the same quarter last year. sell-side analysts anticipate that Omega Healthcare Investors Inc will post 2.97 earnings per share for the current year.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
See Also: Determine Your Level of Risk Tolerance
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors Inc (NYSE:OHI).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.